Clinical toxicity of antibody drug conjugates: a meta-analysis of payloads.

Masters, Joanna C; Nickens, Dana J; Xuan, Dawei; Shazer, Ronald L; Amantea, Michael

Masters, Joanna C; Nickens, Dana J; Xuan, Dawei; Shazer, Ronald L; Amantea, Michael.

Afiliación

Masters JC; Clinical Pharmacology, Oncology, Global Product Development, Pfizer Inc., 10555 Science Center Drive, San Diego, CA, 92121, USA. Joanna.C.Masters@pfizer.com.
Nickens DJ; Global Pharmacometrics, Global Product Development, Pfizer Inc., 10555 Science Center Drive, San Diego, CA, 92121, USA.
Xuan D; Clinical Pharmacology, Early Oncology Development & Clinical Research, Worldwide Research and Development, Pfizer Inc., 10777 Science Center Drive, San Diego, CA, 92121, USA.
Shazer RL; Inspyr Therapeutics, Inc., 31200 Via Colinas, Suite 200, Westlake Village, CA, 91362, USA.
Amantea M; Global Pharmacometrics, Global Product Development, Pfizer Inc., 10555 Science Center Drive, San Diego, CA, 92121, USA.

Invest New Drugs ; 36(1): 121-135, 2018 02.

Article en En | MEDLINE | ID: mdl-29027591

Asunto(s)

Antineoplásicos/efectos adversos; Inmunoconjugados/efectos adversos; Humanos

Palabras clave

Antibody drug conjugates (ADCs); Clinical trials; Meta-analysis; Oncology; Safety; Toxicity

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Inmunoconjugados / Antineoplásicos Tipo de estudio: Systematic_reviews Límite: Humans Idioma: En Revista: Invest New Drugs Año: 2018 Tipo del documento: Article País de afiliación: Estados Unidos

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google